{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:37:44Z","timestamp":1777700264358,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.carpath.2020.107218","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T02:01:20Z","timestamp":1583546480000},"page":"107218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cardiac AA amyloidosis in a patient with obstructive hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-2559","authenticated-orcid":false,"given":"Boyangzi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navneet","family":"Narula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre L.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0846-2205","authenticated-orcid":false,"given":"Daniel G.","family":"Swistel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9499-6456","authenticated-orcid":false,"given":"Daniele","family":"Massera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark V.","family":"Sherrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2020.107218_bib0001","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2796.2005.01522.x","article-title":"Amyloid heart disease mimicking hypertrophic cardiomyopathy","volume":"258","author":"Morner","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.carpath.2020.107218_bib0002","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.111.064246","article-title":"Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide","volume":"125","author":"Philippakis","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2020.107218_bib0003","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2020.107218_bib0004","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.carpath.2020.107218_bib0005","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)","author":"Damy","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carpath.2020.107218_bib0006","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/oxfordjournals.eurheartj.a060225","article-title":"Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis","volume":"13","author":"Hamer","year":"1992","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carpath.2020.107218_bib0007","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2169\/internalmedicine.1099-18","article-title":"First nationwide survey of 199 patients with amyloid A amyloidosis in Japan","volume":"57","author":"Okuda","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.carpath.2020.107218_bib0008","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCULATIONAHA.119.040129","article-title":"Different histopathologic diagnoses in patients with clinically diagnosed hypertrophic cardiomyopathy after surgical myectomy","volume":"140","author":"Alashi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2020.107218_bib0009","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1054-8807(03)00036-X","article-title":"Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy. A study of 204 cases (1996-2000)","volume":"12","author":"Lamke","year":"2003","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2020.107218_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1054-8807(03)00057-7","article-title":"Surgical pathology of subaortic septal myectomy not associated with hypertrophic cardiomyopathy: a study of 98 cases (1996-2000)","volume":"12","author":"Allen","year":"2003","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2020.107218_bib0011","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.amjcard.2014.07.058","article-title":"Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction","volume":"114","author":"Helder","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carpath.2020.107218_bib0012","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880720300223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880720300223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:45:57Z","timestamp":1760960757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880720300223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":12,"alternative-id":["S1054880720300223"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2020.107218","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac AA amyloidosis in a patient with obstructive hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2020.107218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107218"}}